Anthem Blue Cross and Blue Shield Expands Access to Specialty Mental Healthcare Treatment with Addition of InStride Health to Network

 

MANCHESTER, N.H. — As part of Anthem Blue Cross and Blue Shield in New Hampshire’s (Anthem) ongoing effort to increase access to mental healthcare and expand treatment capacity in the state, Anthem recently welcomed InStride Health, a pediatric anxiety and obsessive-compulsive disorder (OCD) treatment provider, to its extensive provider network.

 

InStride Health treats all severity levels for anxiety and OCD for children and young adults ages 7 to 22, with a focus on those with moderate to severe conditions where anxiety and/or OCD are interfering with functioning and causing additional problems (e.g., social isolation, school avoidance, physical symptoms, or depression). InStride Health offers evidence-based treatment through individual and family therapy, patient groups, medication management (if needed), and coaching and care coordination delivered by a highly experienced care team of psychiatrists, therapists, and exposure coaches. Care is delivered virtually.

 

“InStride Health’s results-driven approach to treating pediatric anxiety and OCD offers a much-needed treatment option for our members, and its virtual model offers convenience and flexibility for families,” said Maria Proulx, president of Anthem Blue Cross and Blue Shield in New Hampshire. “This is another example of Anthem Blue Cross and Blue Shield’s continued commitment to expanding access to a variety of mental health treatment options by bringing innovative providers like InStride Health into our expansive network.”

 

InStride Health’s care model is based on their clinical co-founders’ decades of working with kids and families in the Mass General Hospital/McLean Hospital/Harvard Medical School System. “We’ve seen how powerful specialized treatment for pediatric anxiety and OCD can be, and we want to ensure that every child and family has access to that treatment that truly improves lives,” said Mona Potter, co-founder and Chief Medical Officer at InStride Health.

 

Ninety percent of InStride Health program graduates with initial elevated anxiety symptoms at baseline experienced a reduction in anxiety following two months of treatment, with an average symptom reduction of 46 percent. Additionally, after three months of enrollment, 82 percent of patients reported reduced functional impairment and symptom severity.

For more information about InStride Health, visit instride.health.

# # #

 

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of New Hampshire, Inc. HMO plans are administered by Anthem Health Plans of New Hampshire, Inc. and underwritten by Matthew Thornton Health Plan, Inc. Independent licensees of the Blue Cross and Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. The Blue Cross and Blue Shield names and symbols are registered marks of the Blue Cross and Blue Shield Association. Additional information about Anthem Blue Cross and Blue Shield in New Hampshire is available at www.anthem.com. Also, follow us on Twitter at @AnthemBCBS_News and @AnthemBCBS or find us on Facebook.

 

Co-founded by the clinicians who co-developed the McLean Anxiety Mastery Program (MAMP) at McLean Hospital, the nationally recognized program for children and adolescents with moderate to severe anxiety and OCD, InStride Health offers human first, technology-enhanced specialty mental health treatment. Through their proven coordinated care model, InStride is leading the way to provide insurance-based access to treatment of pediatric anxiety and OCD that actually works. Driven by the belief that children and families living with mental health struggles deserve better, InStride is more than a continuum of care—it’s a pathway to a healthier life and hope for a more promising future. www.instride.health.